Eliezer Van Allen, M.D., Dana-Farber Cancer Institute (IMAGE)

Dana-Farber Cancer Institute

Eliezer Van Allen, M.D., Dana-Farber Cancer Institute

Caption

Researchers led by Eliezer Van Allen, M.D., at Dana-Farber Cancer Institute say they have identified unique genomic changes that may be integral to testicular cancer development and explain why the great majority are highly curable with chemotherapy -- unlike most solid tumors.

Credit

Dana-Farber Cancer Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.